KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Raw Materials (2016 - 2019)

NovoCure (NVCR) has disclosed Raw Materials for 6 consecutive years, with $3.4 million as the latest value for Q2 2019.

  • Quarterly Raw Materials rose 36.2% to $3.4 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Jun 2019, up 36.2% year-over-year, with the annual reading at $870000.0 for FY2018, 79.65% down from the prior year.
  • Raw Materials hit $3.4 million in Q2 2019 for NovoCure, up from $1.5 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.9 million in Q3 2017 to a low of $870000.0 in Q4 2018.
  • Historically, Raw Materials has averaged $3.6 million across 5 years, with a median of $3.6 million in 2015.
  • Biggest five-year swings in Raw Materials: surged 568.82% in 2015 and later tumbled 79.65% in 2018.
  • Year by year, Raw Materials stood at $3.5 million in 2015, then soared by 49.03% to $5.2 million in 2016, then dropped by 18.44% to $4.3 million in 2017, then crashed by 79.65% to $870000.0 in 2018, then soared by 294.37% to $3.4 million in 2019.
  • Business Quant data shows Raw Materials for NVCR at $3.4 million in Q2 2019, $1.5 million in Q1 2019, and $870000.0 in Q4 2018.